Clinical Trials

Stomach Neoplasms

NCT06321081 2024-03-20

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Phase 2 Recruiting

60 enrolled

Colorectal Neoplasms

NCT06197438 2024-01-09

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

36 enrolled

Stomach Neoplasms

NCT05799443 2023-04-05

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

23 enrolled

Colorectal Neoplasms

NCT05750290 2023-03-01

CKD-702 Plus Irinotecan in Gastric Cancer

40 enrolled

Stomach Neoplasms

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

40 enrolled

Small Cell Lung Carcinoma

NCT01003964 2022-04-12

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

289 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03380689 2021-03-08

SIRB2

Phase 1 Withdrawn

Colorectal Neoplasms

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

EndocrineGastrointestinalNET

112 enrolled

Gastro-enteropancreatic neuroendocrine tumor

NCT03222089 2018-03-27

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Phase 2 Withdrawn

Colorectal Neoplasms

NCT03030937 2017-01-25

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

74 enrolled

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

35 enrolled

Sarcoma

Recurrence, Sarcoma

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

62 enrolled

Small Cell Lung Carcinoma

NCT00557102 2012-12-11

ERBIFORT

24 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01501669 2012-07-18

PROCEED

Phase 3 Unknown

222 enrolled

Breast

Breast Neoplasms

NCT00620269 2011-11-07

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

212 enrolled

Lung Neoplasms

NCT00874328 2010-10-25

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 1/2 Unknown

74 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00512681 2009-09-18

TIROX2

44 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00506168 2007-07-25

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Phase 2 Terminated

37 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00506207 2007-07-25

TIROX

Phase 1 Unknown

23 enrolled

Gastrointestinal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms

NCT00506571 2007-07-25

TIROX2

42 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00506844 2007-07-25

ERBIRIX

40 enrolled

Rectal Neoplasms

NCT00507143 2007-07-25

Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan

Phase NA Unknown

100 enrolled